Ligand Pharmaceuticals
LGND
LGND
204 hedge funds and large institutions have $1.39B invested in Ligand Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 66 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 196 → 204 (+8)
4% more capital invested
Capital invested by funds: $1.33B → $1.39B (+$55.6M)
2% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 66
Holders
204
Holding in Top 10
4
Calls
$22.6M
Puts
$852K
Top Buyers
| 1 | +$97.8M | |
| 2 | +$8.77M | |
| 3 | +$7.47M | |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
+$4.31M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$3.71M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$8.16M | |
| 3 | -$5.19M | |
| 4 |
BlackRock
New York
|
-$3.38M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$3.27M |